Research Article
CYP19 Genetic Polymorphism Haplotype AASA Is Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer
Table 4
Haplotype AASA remains a significant prognostic factor for poor survival in premenopausal patients receiving adjuvant chemotherapy.
|